Dynavax to Present at the 2019 Cantor Global Healthcare Conference
September 30 2019 - 4:05PM
Dynavax Technologies Corporation (NASDAQ: DVAX), today announced
that Ryan Spencer, Senior Vice President, Commercial, and Interim
Co-President, will present at the 2019 Cantor Global Healthcare
Conference on Friday, Oct. 4, at 12 p.m. E.T.
The presentation will be webcast and may be accessed at the
“Events & Presentations” section of the Company’s website at
http://investors.dynavax.com/events-presentations.
About DynavaxDynavax is a biopharmaceutical
company focused on leveraging the power of the body's innate and
adaptive immune responses through toll-like receptor (TLR)
stimulation. Dynavax discovers, develops and commercializes novel
vaccines. The Company launched its first commercial product,
HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], in
February 2018, following U.S. FDA approval for prevention of
infection caused by all known subtypes of hepatitis B virus in
adults age 18 years and older. For more information, visit
www.dynavax.com.
Contact:
Heather Rowe
Vice President, Investor Relations & Corporate Communications
hrowe@dynavax.com
510-665-7269
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024